Premium
Physician perceptions and beliefs of phase I trials in pediatric oncology
Author(s) -
Gilliam Margaux B.,
MadanSwain Avi,
Adams Julia M.,
Pressey Joseph G.
Publication year - 2013
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.24522
Subject(s) - medicine , pediatric oncology , referral , blood cancer , family medicine , clinical trial , perception , phase (matter) , oncology , cancer , chemistry , organic chemistry , neuroscience , biology
The identification and referral of candidate patients for phase I trials relies heavily on pediatric oncologists who must balance their own perceptions of phase I trials with the desires of the patient and his/her family. A survey was sent to 419 physicians practicing pediatric oncology at 30 different institutions. Results indicated significant differences between physicians who practiced at institutions that participated in phase I consortia versus those who did not. The findings of the survey may be used to enhance the design and execution of phase I trials and to educate oncologists about the goals of phase I trials. Pediatr Blood Cancer 2013;60:E67–E69. © 2013 Wiley Periodicals, Inc.